Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tomas Frgala"'
Publikováno v:
Molecular Cancer Therapeutics. 6:886-897
Purpose: Cytotoxicity assays in 96-well tissue culture plates allow rapid sample handling for multicondition experiments but have a limited dynamic range. Using DIMSCAN, a fluorescence digital image system for quantifying relative cell numbers in tis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba66eeeb42852b6862eeff24218784d6
https://doi.org/10.1158/1535-7163.mct-04-0331
https://doi.org/10.1158/1535-7163.mct-04-0331
Autor:
Vanessa Maldonado, David W. Yesair, Barry J. Maurer, Bee-Chun Sun, C. Patrick Reynolds, Xiaqin Wu, Vazgen Khankaldyyan, Ondrej Kalous, Tomas Frgala, Walter A. Shaw, Stephen W. Burgess, Jitka Janeba, R. Travis McKee
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 13(10)
Purpose: Fenretinide [N-(4-hydroxyphenyl)retinamide (4-HPR)] is a cytotoxic retinoid that suffers from a wide interpatient variation in bioavailability when delivered orally in a corn oil capsule. The poor bioavailability of the capsule formulation m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edb3cbbfbc57e4c6c22fec3d61ea0e66
https://pubmed.ncbi.nlm.nih.gov/17505011
https://pubmed.ncbi.nlm.nih.gov/17505011
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 808(2)
A simple and accurate high-performance liquid chromatography (HPLC) method was developed to measure levels of N-(4-hydroxyphenyl)retinamide (fenretinide, 4-HPR) and its main metabolite N-(4-methoxyphenyl)retinamide (4-MPR) in tissue. Following ultras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24e86b1671b792f117540cb8e8c6365
https://pubmed.ncbi.nlm.nih.gov/15261805
https://pubmed.ncbi.nlm.nih.gov/15261805